Single award · contract
Over the Counter (OTC) COVID-19 Tests
Award ID: 75A50223C00001
FY2023 · complete year · data as of 2026-07-03
A single federal award, with both ends of the trail linked.
$257.1M
Total award value
Award 75A50223C00001 is a contract from the Department of Health and Human Services to Abbott Rapid DX North America LLC, $257.1M obligated, FY2023, for Over the Counter (OTC) COVID-19 Tests. The work is performed in Florida. It is classified as NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing) and PSC 6550 (IN Vitro Diagnostic Substances, Reagents, Test Kits and Sets). Source
Description
The Purpose of This Contract Is to Procure Over the Counter (OTC) COVID-19 Tests.
Award details
Award typeContract
PIID75A50223C00001
Action date2022
Period3 mo
Awarding agencyDepartment of Health and Human Services →
RecipientAbbott Rapid DX North America LLC →
Place of performanceFlorida →
CategoryNAICS 325413PSC 6550
Competed?Not recordedSource
Total (exact)$257,060,695
More awards to Abbott Rapid DX North America LLC
awarded 2022$1.3B
awarded 2021$357M
awarded 2021$265.7M
awarded 2021$264M
awarded 2020$174.4M
More from Department of Health and Human Services
awarded 2025$110.4B
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.